Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding protein with multiple splicing-like pseudogene (RBPMSLP) is a human pseudogene (GeneID: 54032)[2][4][6]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they do not encode active proteins. RBPMSLP is not known to produce a functional RNA-binding protein, nor is it established as a biological therapeutic target. There is no evidence that RBPMSLP plays a direct role in physiology, pathology, or drug response. In contrast, its parent gene, RNA binding protein with multiple splicing (RBPMS), is a functional RNA-binding protein involved in the regulation of alternative splicing, particularly in vascular smooth muscle cell phenotype[1]. However, RBPMSLP itself does not encode a functional protein and lacks any recognized biological or clinical implications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding protein with multiple splicing-like pseudogene (RBPMSLP).